Napro Biotherapeutics, Inc. - NPRO- Profile

Napro BioTherapeutics, Inc.. The Company's principal activities are development, production and licensing of complex natural product pharmaceuticals. The Company also develops and licenses novel genomic technologies for applications in human therapeutics and diagnostics, pharmacogenomics and agrobiotechnology. The Company is focusing primarily on the development, manufacture and commercialization of paclitaxel, a naturally occurring anti cancer agent found in certain species of yew trees. NBT Paclitaxel is the brand name by which the Company markets its paclitaxel products. The Company also exports its products to other countries.